Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Rangering i aksjer #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Aksjekurs
$0.0416118
Markedsverdi
$32.25M
Endring (1 dag)
-1.67%
Endring (1 år)
-59.58%
Land
AU
Handel Neurizon Therapeutics Limited (NUZ)

Kategori

P/B-forhold for Neurizon Therapeutics Limited (NUZ)
P/B-forhold per 2026 TTM: 0
Ifølge Neurizon Therapeutics Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Neurizon Therapeutics Limited fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH